Franklin Biotechnology Valuation
| FBDIX Fund | USD 141.78 0.82 0.58% |
At this time, the entity appears to be overvalued. Franklin Biotechnology shows a prevailing Real Value of $133.81 per share. The current price of the fund is $141.78. We determine the value of Franklin Biotechnology from reviewing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we advise acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will submerge.
Overvalued
Today
Please note that Franklin Biotechnology's price fluctuation is very steady at this time. At this time, the entity appears to be overvalued. Franklin Biotechnology shows a prevailing Real Value of $133.81 per share. The current price of the fund is $141.78. We determine the value of Franklin Biotechnology from reviewing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we advise acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will submerge.
Since Franklin Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Franklin Mutual Fund. However, Franklin Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 141.78 | Real 133.81 | Hype 140.96 | Naive 139.87 |
The intrinsic value of Franklin Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Franklin Biotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Franklin Biotechnology Discovery helps investors to forecast how Franklin mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Franklin Biotechnology more accurately as focusing exclusively on Franklin Biotechnology's fundamentals will not take into account other important factors: Franklin Biotechnology Total Value Analysis
Franklin Biotechnology Discovery is currently forecasted to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Franklin Biotechnology fundamentals before making investing decisions based on enterprise value of the companyFranklin Biotechnology Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Franklin suggests not a very effective usage of assets in November.About Franklin Biotechnology Valuation
Our relative valuation model uses a comparative analysis of Franklin Biotechnology. We calculate exposure to Franklin Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Franklin Biotechnology's related companies.Under normal market conditions, the fund invests at least 80 percent of its net assets in securities of biotechnology companies and discovery research firms. The fund predominantly invests in equity securities. In addition to its investments in biotechnology companies, the fund may also invest up to 20 percent of its net assets in equity or debt securities of any type of issuer. It is non-diversified.
Other Information on Investing in Franklin Mutual Fund
Franklin Biotechnology financial ratios help investors to determine whether Franklin Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Franklin with respect to the benefits of owning Franklin Biotechnology security.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |